Dahlia Biosciences is a startup based in the United States, most recent round Pre-Seed.
Dahlia Biosciences is a startup based in the United States. Its most recent tracked round is Pre-Seed.
Dahlia Biosciences develops multiplexed in situ single-cell RNA analysis tools that integrate with flow cytometry workflows to enable high-throughput, sensitive RNA detection for research and diagnostic applications.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.